OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

THE BRITISH BLOOD TRANSFUSION SOCIETY

(Charitable company limited by guarantee)

REPORT AND UNAUDITED FINANCIAL STATEMENTS

31 MARCH 2021

Registered company number 01723353 Registered charity number 326374

JOSEPH MILLER Chartered Accountants Newcastle upon Tyne

THE BRITISH BLOOD TRANSFUSION SOCIETY (Charitable company limited by guarantee)

CONTENTS

Page

7 Independent examiner’s report 8 Statement of financial activities (including income and expenditure account)

10-16 Notes to the financial statements

18-20 Management information

THE BRITISH BLOOD TRANSFUSION SOCIETY

REFERENCE AND ADMINISTRATIVE INFORMATION

31 MARCH 2021

Council members Dr H Doughty Mrs A Harris Dr G D Poole Mr W Chaffe (resigned 2 December 2020) Ms J White (resigned 2 December 2020) Mrs C E George Mrs C Tuckwell Mr T Bullock (resigned 2 December 2020) Dr I Sullivan Mrs C Howell (resigned 2 December 2020) Mrs L Wong (appointed 2 December 2020) Mr R C Haggas (appointed 2 December 2020) Miss K Veale (appointed 2 December 2020) Miss J Staves (appointed 2 December 2020) Officers President: Dr H Doughty Secretary: Mrs A Harris Treasurer: Mr R C Haggas Registered company number 01723353 Registered charity number 326374 Website www.bbts.org.uk

Registered office Floor A Administration office Unit 22
Milburn House Enterprise House
Dean Street Manchester Science Park
Newcastle upon Tyne Lloyd Street North
NE1 1LE Manchester
M15 6SE
Bankers HSBC Bank plc Independent examiner Mr D R Gold
348 Oxford Road Joseph Miller
Manchester Milburn House
M13 9NG Dean Street
Newcastle upon Tyne
NE1 1LE
Solicitors Hay & Kilner LLP
Merchant House
30 Cloth Market
Newcastle upon Tyne
NE1 1EE

1

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2021

The Council members are pleased to present their report, together with the unaudited financial statements of the Society for the year ended 31 March 2021 which are also prepared to meet the requirements for a directors’ report and financial statements for Companies Act purposes.

Reference and administrative information set out on page 1 form part of this report. The financial statements comply with the Charities Act 2011, the Companies Act 2006, the Memorandum and Articles of Association and the Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with FRS102, the Financial Reporting Standard applicable in the UK and Republic of Ireland.

Structure, governance and management

Governing document

The British Blood Transfusion Society was established in May 1983 as a company limited by guarantee governed by its Memorandum and Articles of Association (revised September 2011). It is registered as a charity with the Charity Commission. Every member undertakes to contribute such an amount not exceeding £1, as may be required in the event of the Society being wound up while he is a member or within one year after he ceases to be a member.

Appointment of Council members

The Council members consist of officers, elected members and Past President or President Elect. Officers consist of the President of the Society who holds office for two years and the Secretary and Treasurer who hold office for three years. The President can remain as a Council member for a further year after retirement from the office of President. The Secretary and Treasurer are eligible for re-appointment by Council, but neither can serve more than six consecutive years in office.

The elected Council members shall be those members of the Council who are not officers and shall each hold office for a period of three years; so far as possible they shall be made up of a mix of professional categories and be representative of the current membership; the period of office may be extended from time to time by the President for a year with a maximum of three extensions providing a maximum term of six years.

The Council members of the charitable company (excluding co-opted members) are its directors for the purposes of company law and trustees for the purposes of charity law. The elected Council members hold office for a period of three years.

Calls for nominations for officers and elected members of Council are made in the BBTS Bloodlines Newsletter and also on the Society’s website. Nominees must be UK members and must have been a member of the Society for a minimum of two years. Nominations must be proposed and seconded by two Society members. Details of the nominees are then published on the ballot papers.

Induction and training of Council members

All new Council members are given an induction pack containing information, links and paperwork about the roles and responsibilities of trustees published by the Charity Commission. They also receive past Council meeting papers and dates of forthcoming Council meetings.

At the first meeting of the new Council, new members are introduced to individual Council members and specific areas of responsibility for new members are discussed and agreed. The Society’s office then provides all the necessary background information and paperwork for new Council members’ individual areas of responsibility.

2

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2021

Organisation

The Society is managed by the Council members, who are responsible for the strategic direction and overview of the work of the Society. The Council members must number at least eight and not more than fourteen, all of whom must be members of the Society. Three Council members (including at least one officer) are needed for a quorum.

There are committees and sub-committees of Council members that may co-opt members who are not members of the Council or Society. Co-opted members may not exceed three-quarters of the total number of such committees. These committees include the Executive Working Committee, the Scientific Meetings Administration Committee, the Communications Committee and the Professional Affairs & Education Committee.

The day to day operations of the charity are managed by the BBTS Executive Manager and a small team of staff from an office based in Manchester.

BBTS Enterprises Limited

The charity’s wholly-owned subsidiary was incorporated in May 2003 and carries out trading activities for the charity. The subsidiary gift aids profits to the charity, subject to the retention of reserves for its own working capital requirements.

Risk management

The members of the Council are responsible for overseeing the risks faced by the Society. Within this process, detailed consideration of risks is delegated to the Executive Manager. Risks are identified, assessed and controls established throughout the year. Risks are held in a risk register. Council conducts ongoing reviews of the major risks to which the Society is exposed.

Objectives and activities

The main aim of the Society is to advance for the public benefit, the study of blood transfusion including immunohaematology and to promote research and development into all aspects of blood transfusion practice.

The objectives of the Society continue to be to:

3

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2021

Objectives and activities (continued)

The Council sets itself annual objectives, in furtherance of the above main objectives of the Society. Each objective has a performance measure and responsibility is allocated to a Council member or Council sub-committee. Performance against the annual objectives is reviewed at Council meetings throughout the year and a progress report published in the Annual Review for members to view.

The Council confirm that they have been given the general guidance produced by the Charity Commission on public benefit including the guidance ‘public benefit running a charity (PB2)’. The Council are confident that public benefit is achieved through the study of blood transfusion and development.

Achievements and performance

The Society’s charitable activities focus on the study of blood transfusion and are undertaken to further its charitable purposes for the public benefit as described in the following paragraphs:

During the year, Council achieved many of its major objectives, including the first examinations for its new Clinical Transfusion Practice course, continuing consistent success for the Transfusion Science Practice course, an improvement and extension of IT software, hardware and support, moving our inductions and exams to online formats for the first time, providing learning and information on BBTS and non BBTS courses, continuing to protect the Society from the financial impact of COVID19.

4

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2021

Achievements and performance (continued)

Membership of the Society has changed during the year as follows:

Number of members on 1 April 2020
Number of new members
Number of members who left
Number of members on 31 March 2021		 1,643
168
(220)
1,591

Financial review

The principal funding sources of the Society are from training income and membership subscriptions. Income from these sources is shown in note 5 to the financial statements.

The net movement in funds for the year was a surplus of £32,273 (2020: £31,639), as shown in the statement of financial activities. There was no gift aid donation (2020: £nil) from the subsidiary this year, so the operational surplus was £32,273 (2020: surplus of £31,639). The group surplus for the year was £44,970 (2020: surplus £43,898).

Reserves policy

Council has established a policy whereby the unrestricted funds not committed, designated or invested in tangible fixed assets (the free reserves) held by the group should equate to at least £400,000. The reserves are needed to meet the ongoing working capital requirements of the group, to bridge any funding gaps during the development of new activities and to enable the group to continue its current activities in the event of a significant drop in income.

The free reserves of the charity as at 31 March 2021 were £352,200 (2020: £320,379) and those of the trading subsidiary add a further £72,068 (2020: £59,371), a total of £424,268 (2020: £379,750).

Investment powers and policy

Under the Memorandum and Articles of Association, the Society has the power to make investments as the Council members see fit.

Having regard to the Society’s liquidity requirements and reserves policy, Council have, in recent years, operated a policy of keeping available funds in interest-bearing deposit accounts.

Plans for future periods

The Council has set itself a number of annual objectives for 2021/22, in furtherance of the main objectives of the Society. These objectives include the following:

5

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2021

Statement of the Council members’ responsibilities in relation to the financial statements

The Council members (who are also directors of the Society for the purposes of company law) are responsible for preparing the report of the Council members and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Council members to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Council members are required to:

The Council members are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Small company provisions

This report has been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.

On behalf of Council

Dr H Doughty President

25 August 2021

6

INDEPENDENT EXAMINER’S REPORT

TO THE MEMBERS AND COUNCIL MEMBERS OF

THE BRITISH BLOOD TRANSFUSION SOCIETY

I report to the Council members on my examination of the financial statements of the company for the year ended 31 March 2021, which are set out on pages 8 to 16.

Responsibilities and basis of report

As the Council members of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s financial statements as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent examiner’s statement

Since the company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or

  2. the financial statements do not accord with those records; or

  3. the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view which is not a matter considered as part of an independent examination; or

  4. the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to Charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

D R Gold BA FCA Independent Examiner Joseph Miller Milburn House Dean Street Newcastle upon Tyne NE1 1LE

25 August 2021

7

THE BRITISH BLOOD TRANSFUSION SOCIETY

STATEMENT OF FINANCIAL ACTIVITIES

(INCLUDING INCOME AND EXPENDITURE ACCOUNT)

FOR THE YEAR ENDED 31 MARCH 2021

Unrestricted Restricted
Note
funds
funds
£
£
Income from:
Donations
4
10,170
38,000
Charitable activities
5
244,274
-
Investments
6
356
-
Total
254,800
38,000
Expenditure on:
Charitable activities
7
222,527
38,000
Net income and movement in funds
32,273
-
Reconciliation of funds:
Total funds brought forward
345,559
-
Total funds carried forward
377,832
-		 Total
2021
£
48,170
244,274
356
292,800
260,527
32,273
345,559
377,832		 Total
2020
£
39,275
304,143
1,659
345,077
313,438
31,639
313,920

345,559

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure was derived from continuing activities.

The notes on pages 10 to 16 form part of these financial statements.

8

THE BRITISH BLOOD TRANSFUSION SOCIETY

BALANCE SHEET

AS AT 31 MARCH 2021

Note
Fixed assets
Intangible assets
9
Tangible assets
10
Investments
11
Current assets
Debtors
12
Cash at bank
Creditors:amounts falling due within
one year
13
Capital grant
Net current assets
Net assets
The funds of the charity
Unrestricted funds
15
Restricted funds
16
Total charity funds		 2021
£
23,356
2,275
1
25,632
66,906
426,723
493,629
(135,097)
(6,332)
352,200
377,832
377,832
-
377,832		 2020
£
23,356
1,823
1
25,180

40,639
413,311
453,950
(127,239)
(6,332)
320,379
345,559
345,559
-
345,559

For the year ended 31 March 2021

the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Council members’ responsibilities:

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Council members and authorised for issue on 25 August 2021 and are signed on their behalf by:

Dr H Doughty President

Mr R C Haggas Treasurer

Company number 01723353

The notes on pages 10 to 16 form part of these financial statements.

9

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

1. Legal status of the charity

The Society is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1.

2. Accounting policies

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:

a) Basis of preparation

The financial statements have been prepared under the historical cost convention with items recognised at cost. They have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities, preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) - (Charities SORP (FRS102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Companies Act 2006.

The financial statements are prepared in sterling which is the functional and presentation currency of the charity.

The British Blood Transfusion Society meets the definition of a public benefit entity under FRS102.

b) Preparation of the accounts on a going concern basis

There is a reasonable expectation that the Society has adequate resources to continue in operational existence for at least the next twelve months and on this basis the Society is considered to be a going concern.

c) Fund structure

i) Restricted funds

General fund

The general fund is credited with subscriptions received from members and income from conferences and meetings. It is charged with the charitable expenditure and governance costs of the Society.

Designated funds

Designated funds comprise unrestricted funds set aside at the discretion of the Council members for particular purposes. The purpose of each designated fund is set out in the notes to the financial statements.

d) Subsidiary undertaking

The investment is included in the financial statements at cost. The financial statements for the Society include only the individual parent charity and are not consolidated to include the trading subsidiary. The parent charity is not required to prepare consolidated financial statements under section 399 of the Companies Act 2006 and is excepted by section 139(2) of the Charities Act 2011 from the requirement to prepare group accounts.

e) Amortisation

Amortisation is calculated so as to write off the cost of the asset, less its estimated residual value, over the useful life of that asset as follows:

Website costs

straight line over 5 years

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

10

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

2. Accounting policies (continued)

f) Fixed assets and depreciation

Tangible fixed assets are included in the financial statements at their historical cost. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost less estimated residual value of the assets over their expected useful lives. The rates used are as follows:

Computer equipment - 25% on straight line basis Furniture and fittings - 20% on straight line basis

g) Investment income

Interest is recognised in the statement of financial activities when receivable.

h) Incoming recognition

All income is included in the statement of financial activities when the charity is entitled to the income and the amount can be quantified with reasonable accuracy. The following specific policies are applied to particular categories of income:

Donations are received by way of grants and donations and are included in full in the statement of financial activities when receivable. Such income is only deferred when the donor specifies that the grant or donation must only be used in future accounting periods, or the donor has imposed conditions which must be met before the Society has unconditional entitlement. Specified donations and grants are included within restricted funds when receivable.

Investment income such as interest and gift aid are included when receivable.

Income from charitable activities includes income from membership subscriptions and training and are recognised in the period in which the Society is entitled to receipt. Deferred income represents amounts received for future periods and is released to the statement of financial activities in the period for which it has been received.

i) Expenditure recognition

Expenditure is included in the statement of financial activities on an accruals basis. Grants payable are charged in the year when the payment is made.

Charitable expenditure comprises all costs of activities in furtherance of the objects of the charity.

Governance costs include those costs incurred in the governance of the charity and compliance with constitutional and statutory requirements.

Support costs comprise staff costs and office overheads which are allocated on the basis of staff time spent on each activity for staff costs and on a basis to reflect the use of the resource for office overheads. These are shown in note 7 to the accounts.

j) Cash at bank

Cash at bank includes a current account and an instant access COIF Charities Deposit Fund account.

k) Creditors and provisions

Creditors and provisions are required where the charity has a present obligation resulting from a past event that will probably result in a transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount.

11

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

2. Accounting policies (continued)

l) Financial instruments

The Society only has financial instruments and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are measured at a transaction value and subsequently measured at their settlement value.

3. Net income

Net income for the year is stated after charging:

2021 2020
£ £
Independent examination and accounting services:
Independent examination 1,020 1,000
Accountancy services 8,275 8,295
Depreciation of tangible fixed assets 643 721
4. Donations Unrestricted Restricted Total Total
funds funds 2021 2020
£ £ £ £
Donations 170 - 170 1,275
Grants 10,000 38,000 48,000 38,000
10,170 38,000 48,170 39,275
5. Charitable activities Unrestricted Unrestricted

funds
funds
2021 2020
£ £
Membership subscriptions 119,977 123,664
Training 124,297 180,479
244,274 304,143
6. Investment income 2021 2020
Gift aid donation from subsidiary undertaking - -
Bank interest 356 1,659
356 1,659

12

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

7. Total resources expended

Charitable Governance
activities
costs
£
£
Direct costs
Meetings and conferences
Publicity and publications
Bursaries and awards
Educational programme
Modernising Scientific Careers
Allocated support costs
Staff costs
Office costs
Depreciation
Accountancy
112
1,534
849
48,366
49,956
91,027
30,729
450
4,647
48
-
-
-
-
11,958
13,170
193
4,648
Legal and professional fees
1,988
852
229,658
30,869
8.
Staff costs and numbers
Wages and salaries

National insurance costs

Pension costs



Average number of employees in the year
 Total
2021
£
160
1,534
849
48,366
49,956
102,985
43,899
643
9,295
2,840
260,527
2021
£
140,034
10,756
7,689
158,479
5		 Total
2020
£
15,920
2,873
13,442
56,808
68,003
95,708
48,526
721
9,295
2,142
313,438
2020
£
165,498
16,522
8,180
190,200
5

The Society considers its key management personnel to be the Council members, the executive director and the chief examiner. The total employment benefits of key management personnel were £94,255 (2020: £99,032). There are no employees with emoluments above £60,000 per annum.

No Council members, or any person related or connected by business to them, received any remuneration. During the year no (2020: 8) Council members were paid £nil (2020: £2,273) as reimbursement for expenses of attending meetings.

13

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

9.
Intangible assets
Cost
At 1 April 2020
Additions
At 31 March 2021
Amortisation
At 1 April 2020 and 31 March 2021
Carrying amount
At 31 March 2021
At 31 March 2020
10. Tangible fixed assets
Furniture Computer
and fittings equipment
£
£
Cost
At 1 April 2020
9,122
5,855
Additions
-
1,095
Disposals
-
(1,626)

At 31 March 2021
9,122
5,324
Depreciation
At 1 April 2020
8,817
4,337
Provided this year
131
512
On disposals
-
(1,626)
At 31 March 2021
8,948
3,223
Net book value
At 31 March 2021
174
2,101
At 1 April 2020
305
1,518		 9.
Intangible assets
Cost
At 1 April 2020
Additions
At 31 March 2021
Amortisation
At 1 April 2020 and 31 March 2021
Carrying amount
At 31 March 2021
At 31 March 2020
10. Tangible fixed assets
Furniture Computer
and fittings equipment
£
£
Cost
At 1 April 2020
9,122
5,855
Additions
-
1,095
Disposals
-
(1,626)

At 31 March 2021
9,122
5,324
Depreciation
At 1 April 2020
8,817
4,337
Provided this year
131
512
On disposals
-
(1,626)
At 31 March 2021
8,948
3,223
Net book value
At 31 March 2021
174
2,101
At 1 April 2020
305
1,518		 Website
£
23,356
-
23,356
-
23,356
23,356
Total
£
14,977
1,095
(1,626)
14,446
13,154
643
(1,626)
12,171
2,275
1,823
9,122
5,324
8,817
4,337
131
512
-
(1,626)
8,948
3,223
174
2,101
305
1,518

14

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

11. Investments

Investment in subsidiary undertaking at cost

2021 2020
£ £
1 1

The Society owns 100% of the issued ordinary share capital of BBTS Enterprises Limited, a company registered in England (company number 4775642).

A summary of the results of BBTS Enterprises Limited for the year ended 31 March 2021 and its financial position as at 31 March 2021, were as follows:

Turnover
Expenditure
Profit for the financial year and retained profit
Aggregate capital and reserves/aggregate assets and liabilities
12. Debtors
Other debtors
Amounts due from subsidiary undertaking
Prepayments and accrued income
13. Creditors: amounts falling due within one year
Other creditors
Social security and other taxes
Accruals
Deferred income (note 14)

14. Deferred income
Balance at 1 April 2020

Subscriptions, meeting and exam fees received

Released to statement of financial activities

Balance at 31 March 2021		 2021
£
117,919
(105,222)
12,697
82,068
2021
£
4,692
56,836
5,378
66,906
2021
£
224
-
10,026
124,847
135,097
2021
£
111,091
124,847
(111,091)
124,847
 2020
£
406,293
(394,034)
12,259
69,371
2020
£
12,483
13,511
14,645
40,639
2020
£
2,670
3,720
9,758
111,091
127,239
2020
£
155,140
111,091
(155,140)
111,091

15

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

15. Unrestricted funds
 Balance at Balance at
1 April 31 March
2020 Income Expenditure 2021
£ £
£		 £
General fund 345,559 254,800 (222,527) 377,832
16. Restricted funds Balance at Balance at
1 April 31 March
2020 Income Expenditure
2021
£ £ £ £
Educational programme fund - 38,000 (38,000) -

The educational programme fund comprises grants received to further education and professional development.

17. Analysis of net assets between funds

Intangible Net
fixed Fixed current
assets assets Investments
assets		 Total
£
£		 £ £ £
Unrestricted funds:
General fund 23,356 2,275 1 352,200 377,832
Restricted fund:
Educational programme fund - - - - -
23,356 2,275 1 352,200 377,832

18. Limited liability

The Society is a company limited by guarantee and every member undertakes to contribute such an amount not exceeding £1, as may be required in the event of the Society being wound up while he is a member or within one year after he ceases to be a member for payment of the debts and liabilities of the Society and for the cost of winding up.

19. Post balance sheet events

The continued impact of the COVID-19 pandemic constitutes a non-adjusting post balance sheet event. It is impossible at this stage to quantify the longer term financial effects on the Society.

16

THE BRITISH BLOOD TRANSFUSION SOCIETY

MANAGEMENT INFORMATION

FOR THE YEAR ENDED 31 MARCH 2021

The following pages do not form part of the statutory financial statements which are the subject of the independent examiner’s report on page 7.

17

THE BRITISH BLOOD TRANSFUSION SOCIETY

SUMMARY INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2021

Income
Core activities
Modernising Scientific Careers
Gift aid donation from trading subsidiary
Expenditure
Core activities
Modernising Scientific Careers



Core activities
Modernising Scientific Careers


Gift aid donation from trading subsidiary

Surplus for the year

 2021
£
282,800
10,000
-

292,800


200,463
60,064


260,527


82,337
(50,064)


32,273

-


32,273

 2020
£
335,077
10,000
-

345,077

245,435
68,003
313,438
89,642
(58,003)
31,639
-
31,639

18

THE BRITISH BLOOD TRANSFUSION SOCIETY

INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2021

Income
Membership subscriptions
Training
Educational programme grant
Government grant
Donations and legacies
Interest receivable



Expenditure
Educational programme
Bursaries and awards
Council expenditure
Meeting costs
Publicity
Staff costs
Staff recruitment and training
Rent and rates
Light and heat
Insurance
Repairs and maintenance
Website, software and computer costs
Other travelling expenses
Telephone
Equipment leasing charges
Postage, printing and stationery
Miscellaneous
Recharge of office overheads to MSC
Subscriptions
Accountancy
Legal and professional fees
Depreciation
Bank and credit card charges



Surplus before MSC

Modernising Scientific Careers (MSC) deficit(Page 20)

Gift aid donation from trading subsidiary

Surplus for the year

 2021
£
119,977
124,297
28,000
10,000
170
356
282,800
61,524
849
160
-
1,534
79,718
-
26,541
603
945
185
5,498
(424)
4,231
1,436
2,976
293
(3,376)
2,997
9,295
2,840
643
1,995
200,463

82,337

(50,064)

-
32,273
 2020
£
123,664
180,479
28,000
-
1,275
1,659
335,077
56,808
13,442
15,166
754
2,407
95,708
483
24,971
913
850
181
9,722
1,105
3,431
1,134
4,758
300
(3,719)
3,078
9,295
2,142
721
1,785
245,435
89,642
(58,003)
-
31,639

19

THE BRITISH BLOOD TRANSFUSION SOCIETY

MODERNISING SCIENTIFIC CAREERS

INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2021


Income
Modernising Scientific Careers grant
Expenditure
Staff costs
Staff secondment costs
Printing and postage


Meeting costs
Travelling expenses
Website, software and computer costs
Computer maintenance
Books and publications
Bank and credit card charges
Recharge of office overheads

Deficit for the year		 2021
£
10,000

53,675
-
14


1,165
-
964
862
-
8
3,376
60,064
(50,064)
 2020
£
10,000
56,842
239
18
4,851
1,375
-
728
224
7
3,719
68,003
(58,003)

20